Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Improved glycemic control with proximal intestinal bypass and weight loss following gastrectomy in non-obese diabetic gastric cancer patients.

Guner A, Cho M, Son T, Kim HI, Noh SH, Hyung WJ.

Oncotarget. 2017 Nov 1;8(61):104605-104614. doi: 10.18632/oncotarget.22262. eCollection 2017 Nov 28.

2.

Effects of Laparoscopic Roux-en-Y Gastric Bypass for Type 2 Diabetes Mellitus: Comparison of BMI > 30 and < 30 kg/m2.

Ke Z, Li F, Chen J, Gao Y, Zhou X, Sun F, Li C, Liu B, Li Q, Zhu Z, Tong W.

Obes Surg. 2017 Nov;27(11):3040-3047. doi: 10.1007/s11695-017-2926-9.

3.

Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass.

Tharakan G, Behary P, Wewer Albrechtsen NJ, Chahal H, Kenkre J, Miras AD, Ahmed AR, Holst JJ, Bloom SR, Tan T.

Eur J Endocrinol. 2017 Dec;177(6):455-464. doi: 10.1530/EJE-17-0446. Epub 2017 Aug 30.

4.

Variations in diabetes remission rates after bariatric surgery in Spanish adults according to the use of different diagnostic criteria for diabetes.

Alhambra-Expósito MR, Molina-Puerta MJ, Prior-Sánchez MI, Manzano-García G, Calañas-Continente A, Gálvez-Moreno MA.

BMC Endocr Disord. 2017 Aug 15;17(1):51. doi: 10.1186/s12902-017-0201-7.

5.

The role of bariatric surgery to treat diabetes: current challenges and perspectives.

Koliaki C, Liatis S, le Roux CW, Kokkinos A.

BMC Endocr Disord. 2017 Aug 10;17(1):50. doi: 10.1186/s12902-017-0202-6. Review.

6.

All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes.

Lent MR, Benotti PN, Mirshahi T, Gerhard GS, Strodel WE, Petrick AT, Gabrielsen JD, Rolston DD, Still CD, Hirsch AG, Zubair F, Cook A, Carey DJ, Wood GC.

Diabetes Care. 2017 Oct;40(10):1379-1385. doi: 10.2337/dc17-0519. Epub 2017 Jul 31.

PMID:
28760742
7.

Decreased Cardiovascular Risk after Roux-en-Y Gastric Bypass Surgery in Chinese Diabetic Patients with Obesity.

Zhao X, Duan W, Sun C, Li Z, Liu Y, Xiao X, Wang G, Gang X, Wang G.

J Diabetes Res. 2017;2017:5612049. doi: 10.1155/2017/5612049. Epub 2017 Jul 4.

8.

Does bariatric surgery prevent progression of diabetic retinopathy?

Chen Y, Laybourne JP, Sandinha MT, de Alwis NMW, Avery P, Steel DH; Medscape.

Eye (Lond). 2017 Aug;31(8):1131-1139. doi: 10.1038/eye.2017.119. Epub 2017 Jul 21.

PMID:
28731054
9.

Performance of the DiaRem Score for Predicting Diabetes Remission in Two Health Systems Following Bariatric Surgery Procedures in Hispanic and non-Hispanic White Patients.

Craig Wood G, Horwitz D, Still CD, Mirshahi T, Benotti P, Parikh M, Hirsch AG.

Obes Surg. 2018 Jan;28(1):61-68. doi: 10.1007/s11695-017-2799-y.

PMID:
28717860
10.

A prospective 4-year study of insulin resistance and adipokines in morbidly obese diabetic and non-diabetic patients after gastric banding.

Urbanavicius V, Juodeikis Z, Dzenkeviciute V, Galkine A, Petrulioniene Z, Sapoka V, Brimiene V, Vitkus D, Brimas G.

Wideochir Inne Tech Maloinwazyjne. 2017 Jun;12(2):147-153. doi: 10.5114/wiitm.2017.67207. Epub 2017 Apr 13.

11.

Concordance between Research Sequencing and Clinical Pharmacogenetic Genotyping in the eMERGE-PGx Study.

Rasmussen-Torvik LJ, Almoguera B, Doheny KF, Freimuth RR, Gordon AS, Hakonarson H, Hawkins JB, Husami A, Ivacic LC, Kullo IJ, Linderman MD, Manolio TA, Obeng AO, Pellegrino R, Prows CA, Ritchie MD, Smith ME, Stallings SC, Wolf WA, Zhang K, Scott SA.

J Mol Diagn. 2017 Jul;19(4):561-566. doi: 10.1016/j.jmoldx.2017.04.002. Epub 2017 May 11.

PMID:
28502727
12.

Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study.

Carlsson LMS, Sjöholm K, Karlsson C, Jacobson P, Andersson-Assarsson JC, Svensson PA, Larsson I, Hjorth S, Neovius M, Taube M, Carlsson B, Peltonen M.

Lancet Diabetes Endocrinol. 2017 Apr;5(4):271-279. doi: 10.1016/S2213-8587(17)30061-X. Epub 2017 Feb 23.

PMID:
28237791
13.

Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS).

Peterli R, Wölnerhanssen BK, Vetter D, Nett P, Gass M, Borbély Y, Peters T, Schiesser M, Schultes B, Beglinger C, Drewe J, Bueter M.

Ann Surg. 2017 Mar;265(3):466-473. doi: 10.1097/SLA.0000000000001929.

14.

Surgical Treatment of Metabolic Syndrome.

Runkel N, Brydniak R.

Visc Med. 2016 Oct;32(5):352-356. Epub 2016 Sep 28. Review.

15.

The Newfoundland and Labrador Bariatric Surgery Cohort Study: Rational and Study Protocol.

Twells LK, Gregory DM, Midodzi WK, Dillon C, Kovacs CS, MacDonald D, Lester KK, Pace D, Smith C, Boone D, Murphy R.

BMC Health Serv Res. 2016 Oct 28;16(1):618.

16.

National Differences in Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery-Subgroup Analysis of 2-Year Results of the Diabetes Surgery Study Comparing Taiwanese with Americans with Mild Obesity (BMI 30-35 kg/m2).

Chong K, Ikramuddin S, Lee WJ, Billington CJ, Bantle JP, Wang Q, Thomas AJ, Connett JE, Leslie DB, Inabnet WB 3rd, Jeffery RW, Sarr MG, Jensen MD, Vella A, Ahmed L, Belani K, Schone JL, Olofson AE, Bainbridge HA, Laqua PS, Korner J, Chuang LM.

Obes Surg. 2017 May;27(5):1189-1195. doi: 10.1007/s11695-016-2433-4.

17.

Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass?

Chondronikola M, Harris LL, Klein S.

J Intern Med. 2016 Nov;280(5):476-486. doi: 10.1111/joim.12527. Epub 2016 Oct 14. Review.

18.

Limitations of the DiaRem Score in Predicting Remission of Diabetes Following Roux-En-Y Gastric Bypass (RYGB) in an ethnically Diverse Population from a Single Institution in the UK.

Tharakan G, Scott R, Szepietowski O, Miras AD, Blakemore AI, Purkayastha S, Ahmed A, Chahal H, Tan T.

Obes Surg. 2017 Mar;27(3):782-786. doi: 10.1007/s11695-016-2368-9.

19.

Sleeve gastrectomy versus Roux-en-Y gastric bypass for type 2 diabetes and morbid obesity: double-blind randomised clinical trial protocol.

Murphy R, Evennett NJ, Clarke MG, Robinson SJ, Humphreys L, Jones B, Kim DD, Cutfield R, Plank LD, Hammodat H, Booth MW.

BMJ Open. 2016 Jul 4;6(7):e011416. doi: 10.1136/bmjopen-2016-011416.

20.

Post-Bariatric Surgery Changes in Quinolinic and Xanthurenic Acid Concentrations Are Associated with Glucose Homeostasis.

Favennec M, Hennart B, Verbanck M, Pigeyre M, Caiazzo R, Raverdy V, Verkindt H, Leloire A, Guillemin GJ, Yengo L, Allorge D, Froguel P, Pattou F, Poulain-Godefroy O.

PLoS One. 2016 Jun 21;11(6):e0158051. doi: 10.1371/journal.pone.0158051. eCollection 2016.

Supplemental Content

Support Center